Back to Search
RAVEENDRA RAVI, M.D.
M.D.
Urology Physician
NPI: 1033399522Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Resistance of cancers to immunologic cytotoxicity and adoptive immunotherapy via X-linked inhibitor of apoptosis protein expression and coexisting defects in mitochondrial death signaling.
PMID 16452233·Cancer Res·2006
7-preclinical
Elimination of hepatic metastases of colon cancer cells via p53-independent cross-talk between irinotecan and Apo2 ligand/TRAIL.
PMID 15604280·Cancer Res·2004
7-preclinical
Assays for raf-1 kinase phosphorylation and activity in human small cell lung cancer cells.
PMID 12415695·Methods Mol Med·2003
8-other
Sensitization of tumor cells to Apo2 ligand/TRAIL-induced apoptosis by inhibition of casein kinase II.
PMID 12154014·Cancer Res·2002
8-other
Requirement of BAX for TRAIL/Apo2L-induced apoptosis of colorectal cancers: synergism with sulindac-mediated inhibition of Bcl-x(L).
PMID 11912124·Cancer Res·2002
8-other
Potential methods to circumvent blocks in apoptosis in lymphomas.
PMID 12192267·Curr Opin Oncol·2002
6-review
Regulation of death receptor expression and TRAIL/Apo2L-induced apoptosis by NF-kappaB.
PMID 11283615·Nat Cell Biol·2001
7-preclinical
Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha.
PMID 10640274·Genes Dev·2000
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2421 LAKE AVE
ASHTABULA, OH 44004 - Phone
- (440) 997-0092
Quick Facts
- NPI
- 1033399522
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile